187 related articles for article (PubMed ID: 17209221)
1. Approach to the patient with subclinical hyperthyroidism.
Cooper DS
J Clin Endocrinol Metab; 2007 Jan; 92(1):3-9. PubMed ID: 17209221
[TBL] [Abstract][Full Text] [Related]
2. Subclinical hyperthyroidism: controversies in management.
Shrier DK; Burman KD
Am Fam Physician; 2002 Feb; 65(3):431-8. PubMed ID: 11858626
[TBL] [Abstract][Full Text] [Related]
3. Update on subclinical hyperthyroidism.
Donangelo I; Braunstein GD
Am Fam Physician; 2011 Apr; 83(8):933-8. PubMed ID: 21524033
[TBL] [Abstract][Full Text] [Related]
4. [Is there a need for treatment in subclinical hypo- and hyperthyroidism?].
Lerch M; Meier C; Staub JJ
Ther Umsch; 1999 Jul; 56(7):369-73. PubMed ID: 10434773
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.
Faber J; Wiinberg N; Schifter S; Mehlsen J
Eur J Endocrinol; 2001 Oct; 145(4):391-6. PubMed ID: 11580994
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
Bayer MF; Kriss JP; McDougall IR
J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
[TBL] [Abstract][Full Text] [Related]
7. Subclinical hyperthyroidism and atrial fibrillation.
Sawin CT
Thyroid; 2002 Jun; 12(6):501-3. PubMed ID: 12165113
[TBL] [Abstract][Full Text] [Related]
8. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
9. Low thyrotropin (TSH) levels in goiter. Relationship with scintigraphic findings and other biological parameters.
Talbot JN; Duron F; Piketty ML; Habert MO; Laforest MD; Milhaud G
Thyroidology; 1989 Apr; 1(1):39-44. PubMed ID: 2484906
[TBL] [Abstract][Full Text] [Related]
10. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
11. Severe but not mild alterations of thyroid function modulate the density of thyroid-stimulating hormone receptors in the rat thyroid gland.
Denereaz N; Lemarchand-Beraud T
Endocrinology; 1995 Apr; 136(4):1694-700. PubMed ID: 7895680
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover in overt and subclinical hyperthyroidism due to autonomous thyroid adenoma.
De Menis E; Da Rin G; Roiter I; Legovini P; Foscolo G; Conte N
Horm Res; 1992; 37(6):217-20. PubMed ID: 1292974
[TBL] [Abstract][Full Text] [Related]
13. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.
Biondi B; Palmieri EA; Fazio S; Cosco C; Nocera M; Saccà L; Filetti S; Lombardi G; Perticone F
J Clin Endocrinol Metab; 2000 Dec; 85(12):4701-5. PubMed ID: 11134131
[TBL] [Abstract][Full Text] [Related]
14. Should we treat mild subclinical/mild hyperthyroidism? No.
Vanderpump MP
Eur J Intern Med; 2011 Aug; 22(4):330-3. PubMed ID: 21767747
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease, multinodular goiter and subclinical hyperthyroidism.
Bel Lassen P; Kyrilli A; Lytrivi M; Corvilain B
Ann Endocrinol (Paris); 2019 Sep; 80(4):240-249. PubMed ID: 31427038
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
17. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
18. Subclinical hyperthyroidism and cardiovascular risk: recommendations for treatment.
Palmeiro C; Davila MI; Bhat M; Frishman WH; Weiss IA
Cardiol Rev; 2013; 21(6):300-8. PubMed ID: 23563523
[TBL] [Abstract][Full Text] [Related]
19. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study.
Rosario PW
Clin Endocrinol (Oxf); 2010 May; 72(5):685-8. PubMed ID: 20447066
[TBL] [Abstract][Full Text] [Related]
20. [Subclinical hyperthyroidism: from diagnosis to treatment].
Corvilain B
Rev Med Brux; 2012 Sep; 33(4):241-5. PubMed ID: 23091927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
